Wednesday, May 1, 2024
Mitochondrial Health

What do we know about ME/CFS* in 2019? An update on current research



*ME/CFS is Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Dr Eiren Sweetman
Post-Doctoral Fellow, Prof Warren Tate’s Research Team
Department of Biochemistry, University of Otago, Dunedin, New Zealand
alumni.otago.ac.nz/donate/myalgic-encephalomyelitis

Presentation hosted by ME/CFS Group Canterbury
www.mecfscanterbury.nz
Thursday, 31st October 2019, 7pm
The Atrium Function Centre, Hagley Park, Christchurch, New Zealand

Schedule:
00:00 Introduction by Anna Grenfell, RN, ME/CFS Group Canterbury
01:08 Introduction to ME/CFS
03:37 Research approach at the University of Otago
06:20 Proteome Study
13:19 Mitochondria function Study
18:33 Transcriptome (expressed genes) Study
21:25 Epigenetics Study
22:30 Neuroinflammation /stress centre Hypothesis
26:00 Cortene trial
27:20 Dr Rob Phair – the IDO metabolic trap
30:39 Dr Ronald W Davis & team – promising Nanoneedle diagnostic test
32:47 Growing collaboration
34:37 Questions
54:20 Thank you Dr Sweetman
54:53 The work of ME/CFS Group Canterbury
58:12 Summary Notes
58:41 For more Information slide

Thank you for your interest

For more information:
+ M.E. /CFS Group Canterbury – www.mecfscanterbury.nz
+ The Associated NZ ME Society – www.anzmes.org.nz
+ M.E. Awareness NZ – www.m.e.awareness.nz
+ CDC – www.cdc.gov/me-cfs/healthcare-providers

NZ Researchers involved in ME/CFS research:
+ Prof Warren Tate & team, University of Otago
+ Dr Lynette Hodges, Massey University
+ Dr Carolyn Wilshire, Victoria University
+ Dr Don Baken, Massey University

source

Similar Posts